Back to Screener

Aclarion, Inc. Warrant (ACONW)

Price$0.04

Favorite Metrics

Price vs S&P 500 (26W)24.38%
Price vs S&P 500 (4W)-10.43%

All Metrics

Price vs S&P 500 (YTD)8.99%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.02M
52-Week High$0.23
26-Week Price Return33.12%
13-Week Price Return12.83%
3-Month Return Std Dev218.38%
Year-to-Date Return11.35%
5-Day Price Return14.05%
Month-to-Date Return-11.72%
Price vs S&P 500 (13W)9.97%
Beta-0.92x
52-Week Low$0.02

Industry Peers — Health Services(21)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
ACONWAclarion, Inc. Warrant
$0.04
NTRANatera, Inc. Common Stock
35.90%-13.44%-15.28%$207.74
LHLabcorp Holdings Inc.
25.31x7.25%9.92%10.28%$269.19
DGXQuest Diagnostics Inc.
21.75x11.78%14.10%13.88%$196.31
EXASExact Sciences Corp
17.69%-6.35%-8.51%$104.91
GHGuardant Health, Inc. Common Stock
32.88%-45.02%-246.60%$91.07
RDNTRadNet, Inc. Common Stock
1779.27x11.51%3.04%-1.88%$57.85
VCYTVeracyte, Inc.
39.66x16.01%11.17%5.33%$33.45
GRALGRAIL, Inc. Common Stock
17.18%-381.98%-17.11%$51.20
CDNACareDx, Inc.
18.34x13.79%-8.10%-6.47%$21.29
FTREFortrea Holdings Inc. Common Stock
1.00%-32.04%-152.17%$10.44

About

Aclarion Inc is a healthcare technology company that develops Nociscan, a SaaS platform using proprietary Magnetic Resonance Spectroscopy to help physicians identify painful versus non-painful spinal discs. The platform generates revenues through diagnostic reports delivered to medical professionals in the United States. The company's revenue is currently concentrated in a single product offering.